about
Calcitonin receptor expression in medullary thyroid carcinomaProtein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life.Proteinuria is a late-onset adverse event in patients treated with cabozantinibNon thyroidal second primary malignancies in differentiated thyroid cancer patients: is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Virginia Cappagli
@ast
Virginia Cappagli
@de
Virginia Cappagli
@en
Virginia Cappagli
@es
Virginia Cappagli
@fr
Virginia Cappagli
@nl
type
label
Virginia Cappagli
@ast
Virginia Cappagli
@de
Virginia Cappagli
@en
Virginia Cappagli
@es
Virginia Cappagli
@fr
Virginia Cappagli
@nl
prefLabel
Virginia Cappagli
@ast
Virginia Cappagli
@de
Virginia Cappagli
@en
Virginia Cappagli
@es
Virginia Cappagli
@fr
Virginia Cappagli
@nl
P106
P1153
54398256500
P21
P31
P496
0000-0003-0726-8125